Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Phase 2
Recruiting
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Biological: ATL administration
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Lukas Biomedical Inc.
- Target Recruit Count
- 95
- Registration Number
- NCT05304481
- Locations
- 🇨🇳
Hualien Tzu Chi Hospital, Hualien City, Taiwan
🇨🇳E-Da Cancer Treatment Hospital, Kaohsiung, Taiwan
🇨🇳Far Estern Memorial Hospital, New Taipei City, Taiwan
News
No news found